The Finnish leukaemia group: levamisole in maintenance therapy of acute myeloid leukemia in adults.
Recent Results Cancer Res
; 80: 70-2, 1982.
Article
en En
| MEDLINE
| ID: mdl-6949237
ABSTRACT
The Finnish Leukaemia Group has carried out a randomized, multicenter trial to study the effect of levamisole on the remission maintained with 6-mercaptopurine and methotrexate in acute myeloid leukaemia in adults. Levamisole was given on 3 consecutive days every 2 weeks. Twenty-five patients received only chemotherapy, while 26 patients received levamisole as well. The patients receiving levamisole showed significantly better remission duration than those given only chemotherapy (P = 0.033, Mantel's summary chi 2-text). There are four long term survivors in the levamisole group versus none in the chemotherapy group. The remissions have lasted 48-75 months.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Leucemia Mieloide Aguda
/
Levamisol
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Límite:
Adult
/
Aged
/
Humans
/
Middle aged
Idioma:
En
Año:
1982
Tipo del documento:
Article